The human IgE repertoire

International Archives of Allergy and Immunology

Volumn 163, Issue 2, 2014, Pages 77-91

  Gadermaier, Elisabeth ^a   Levin, Mattias ^b   Flicker, Sabine ^a   Ohlin, Mats ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Antigen specificity; Antigen specific IgE; Basic clinical immunology; Combinatorial antibody library; Epitopes; Genetic engineering; IgE antibody specificity; IgE epitopes; IgE repertoire; Monoclonal antibodies; Phage display; Specific human IgE

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN HEAVY CHAIN; MONOCLONAL ANTIBODY; OLIGOCLONAL BAND; TRANSCRIPTOME;

ALLERGY; ANTIBODY ENGINEERING; ANTIBODY LIBRARY; ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTATION; EFFECTOR CELL; GENE; HEAVY CHAIN; HUMAN; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE FUNCTION; MUTATION; PHAGE DISPLAY; PRIORITY JOURNAL; REVIEW; ALLERGIC DISEASE; ANTIBODY RESPONSE; ANTIBODY STRUCTURE; ANTIGEN BINDING; ANTIGEN SPECIFICITY; AUTOIMMUNITY; B LYMPHOCYTE; CIRCULATION; CLINICAL PRACTICE; GENE SEQUENCE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; MEDICAL RESEARCH; MOLECULAR INTERACTION; PRE B LYMPHOCYTE; PROTEIN QUATERNARY STRUCTURE; SOMATIC HYPERMUTATION; T LYMPHOCYTE ACTIVATION;

ALLERGENS; ANIMALS; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; COMBINATORIAL CHEMISTRY TECHNIQUES; GENETIC ENGINEERING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; HYPERSENSITIVITY; IMMUNITY, HUMORAL; IMMUNOGLOBULIN E; IMMUNOTHERAPY; RECEPTORS, ANTIGEN, B-CELL; TRANSCRIPTOME;

EID: 84896690346     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000355947     Document Type: Review

References (151)

1. Floistrup H, Swartz J, Bergstrom A, et al: Allergic disease and sensitization in Steiner school children. J Allergy Clin Immunol 2006; 117: 59-66.
2. Larche M, Akdis CA, Valenta R: Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 2006; 6: 761-771.
3. Ishizaka K, Ishizaka T: Identification of Eantibodies as a carrier of reaginic activity. J Immunol 1967; 99: 1187-1198.
4. Johansson SG: The history of IgE: from discovery to 2010. Curr Allergy Asthma Rep 2011; 11: 173-177.
5. Stanworth DR, Humphrey JH, Bennich H, Johansson SGO: Specific inhibition of the Prausnitz-Ku stner reaction by an atypical human myeloma protein. Lancet 1967; 2: 330-332.
6. Wide L, Bennich H, Johansson SG: Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet 1967; 2: 1105-1107.
7. Fang KS, Vitale M, Fehlner P, King TP: cDNA cloning and primary structure of a white-face hornet venom allergen, antigen 5. Proc Natl Acad Sci USA 1988; 85: 895-899.
8. Chua KY, Stewart GA, Thomas WR, et al: Sequence analysis of cDNA coding for a major house dust mite allergen, Der p 1. Homology with cysteine proteases. J Exp Med 1988; 167: 175-182.
9. Thomas WR, Stewart GA, Simpson RJ, et al: Cloning and expression of DNA coding for the major house dust mite allergen Der p 1 in Escherichia coli . Int Arch Allergy Appl Immunol 1988; 85: 127-129.
10. Breiteneder H, Pettenburger K, Bito A, et al: The gene coding for the major birch pollen allergen Betv1, is highly homologous to a pea disease resistance response gene. EMBO J 1989; 8: 1935-1938.
11. Mari A, Scala E: Allergome: a unifying platform. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf AM 2006; 95: 29-39.
12. Radauer C, Bublin M, Wagner S, Mari A, Breiteneder H: Allergens are distributed into few protein families and possess a restricted number of biochemical functions. J Allergy Clin Immunol 2008; 121: 847-852.
13. Chapman MD, Pomes A, Breiteneder H, Ferreira F: Nomenclature and structural biology of allergens. J Allergy Clin Immunol 2007; 119: 414-420.
14. Valenta R, Lidholm J, Niederberger V, et al: The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999; 29: 896-904.
15. Heiss S, Mahler V, Steiner R, et al: Component- resolved diagnosis (CRD) of type I allergy with recombinant grass and tree pollen allergens by skin testing. J Invest Dermatol 1999; 113: 830-837.
16. Hiller R, Laffer S, Harwanegg C, et al: Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002; 16: 414-416.
17. Valenta R, Linhart B, Swoboda I, Niederberger V: Recombinant allergens for allergen-specific immunotherapy years anniversary of immunotherapy with recombinant allergens. Allergy 2011; 66: 775-783.
18. Xu JL, Davis MM: Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities. Immunity 2000; 13: 37-45.
19. Venet S, Ravn U, Buatois V, et al: Transferring the characteristics of naturally occurring and biased antibody repertoires to human antibody libraries by trapping CDRH3 sequences. PLoS One 2012; 7:e43471.
20. Gadermaier E, Flicker S, Lupinek C, Steinberger P, Valenta R: Determination of allergen specificity by heavy chains in grass pollen allergen-specific IgE antibodies. J Allergy Clin Immunol 2013; 131: 1185-1193.
21. Lefranc MP, Giudicelli V, Ginestoux C, et al: IMGT , the international ImMunoGeneTics information system . Nucl Acids Res 2009; 37:D1006-D1012.
22. Cook GP, Tomlinson IM, Walter G, et al: A map of the human immunoglobulin VH locus completed by analysis of the telomeric region of chromosome 14q. Nat Genet 1994; 7: 162-168.
23. Corbett SJ, Tomlinson IM, Sonnhammer ELL, Buck D, Winter G: Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, minor D segments or D-D recombination. J Mol Biol 1997; 270: 587-597.
24. Ravetch JV, Siebenlist U, Korsmeyer S, Waldmann T, Leder P: Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes. Cell 1981; 27: 583-591.
25. Tomlinson IM, Walter G, Marks JD, Llewelyn MB, Winter G: The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol 1992; 227: 776-798.
26. Kidd MJ, Chen Z, Wang Y, et al: The inference of phased haplotypes for the immunoglobulin H chain V region gene loci by analysis of VDJ gene rearrangements. J Immunol 2012; 188: 1333-1340.
27. Boyd SD, Gaeta BA, Jackson KJ, et al: Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements. J Immunol 2010; 184: 6986-6992.
28. Watson CT, Breden F: The immunoglobulin heavy chain locus: genetic variation, missing data, and implications for human disease. Genes Immun 2012; 13: 363-373.
29. Barrios Y, Jirholt P, Ohlin M: Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor. J Mol Recognit 2004; 17: 332-338.
30. Cupps TR, Goldsmith PK, Volkman DJ, et al: Activation of human peripheral blood B cells following immunization with hepatitis B surface antigen vaccine. Cell Immunol 1984; 86: 145-154.
31. Falkoff RJ, Zhu LP, Fauci AS: The relationship between immunization and circulating antigen- specific plaque-forming cells. Cell Immunol 1983; 78: 392-399.
32. Wrammert J, Smith K, Miller J, et al: Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008; 453: 667-671.
33. Poulsen TR, Meijer PJ, Jensen A, Nielsen LS, Andersen PS: Kinetic, affinity, and diversity limits of human polyclonal antibody responses against tetanus toxoid. J Immunol 2007; 179: 3841-3850.
34. Snow RE, Chapman CJ, Frew AJ, Holgate ST, Stevenson FK: Pattern of usage and somatic hypermutation in the V(H)5 gene segments of a patient with asthma: implications for IgE. Eur J Immunol 1997; 27: 162-170.
35. Snow RE, Djukanovic R, Stevenson FK: Analysis of immunoglobulin E VH transcripts in a bronchial biopsy of an asthmatic patient confirms bias towards VH5, and indicates local clonal expansion, somatic mutation and isotype switch events. Immunology 1999; 98: 646-651.
36. Coker HA, Harries HE, Banfield GK, et al: Biased use of VH5 IgE-positive B cells in the nasal mucosa in allergic rhinitis. J Allergy Clin Immunol 2005; 116: 445-452.
37. Edwards MR, Brouwer W, Choi CH, et al: Analysis of IgE antibodies from a patient with atopic dermatitis: biased V gene usage and evidence for polyreactive IgE heavy chain complementarity-determining region 3. J Immunol 2002; 168: 6305-6313.
38. Janezic A, Chapman CJ, Snow RE, et al: Immunogenetic analysis of the heavy chain variable regions of IgE from patients allergic to peanuts. J Allergy Clin Immunol 1998; 101: 391-396.
39. Wang Y, Jackson KJ, Chen Z, et al: IgE sequences in individuals living in an area of endemic parasitism show little mutational evidence of antigen selection. Scand J Immunol 2011; 73: 496-504.
40. Dahlke I, Nott DJ, Ruhno J, Sewell WA, Collins AM: Antigen selection in the IgE response of allergic and nonallergic individuals. J Allergy Clin Immunol 2006; 117: 1477-1483.
41. Davies JM, Platts-Mills TA, Aalberse RC: The enigma of IgE+ B-cell memory in human subjects. J Allergy Clin Immunol 2013; 131: 972-976.
42. Levin M, Ohlin M: Inconclusive evidence for or against positive antigen selection in the shaping of human IgE repertoires - a call for new approaches. Int Arch Allergy Immunol 2013; 161: 122-126.
43. Davies JM, OHehir RE: VH gene usage in immunoglobulin E responses of seasonal rhinitis patients allergic to grass pollen is oligoclonal and antigen driven. Clin Exp Allergy 2004; 34: 429-436.
44. Kerzel S, Rogosch T, Struecker B, Maier RF, Zemlin M: IgE transcripts in the circulation of allergic children reflect a classical antigen-driven B cell response and not a superantigen-like activation. J Immunol 2010; 185: 2253-2260.
45. Pratt E, Collins AM, Sewell WA, Harvey RJ: Antigen selection in IgE antibodies from individuals with chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 2010; 24: 416-421.
46. MacDonald CM, Boursier L, DCruz DP, Dunn-Walters DK, Spencer J: Mathematical analysis of antigen selection in somatically mutated immunoglobulin genes associated with autoimmunity. Lupus 2010; 19: 1161-1170.
47. Coker HA, Durham SR, Gould HJ: Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J Immunol 2003; 171: 5602-5610.
48. Gould HJ, Takhar P, Harries HE, Durham SR, Corrigan CJ: Germinal-centre reactions in allergic inflammation. Trends Immunol 2006; 27: 446-452.
49. Gevaert P, Nouri-Aria KT, Wu H, et al: Local receptor revision and class switching to IgE in chronic rhinosinusitis with nasal polyps. Allergy 2013; 68: 55-63.
50. Takhar P, Corrigan CJ, Smurthwaite L, et al: Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma. J Allergy Clin Immunol 2007; 119: 213-218.
51. Takhar P, Smurthwaite L, Coker HA, et al: Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis. J Immunol 2005; 174: 5024-5032.
52. KleinJan A, Vinke JG, Severijnen LW, Fokkens WJ: Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J 2000; 15: 491-497.
53. Rondon C, Romero JJ, Lopez S, et al: Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol 2007; 119: 899-905.
54. Levin M, Tan LW, Baker L, et al: Diversity of IgE-encoding transcripts in sinus mucosa of subjects diagnosed with non-allergic fungal eosinophilic sinusitis. Clin Exp Allergy 2011; 41: 811-820.
55. Smurthwaite L, Walker SN, Wilson DR, et al: Persistent IgE synthesis in the nasal mucosa of hay fever patients. Eur J Immunol 2001; 31: 3422-3431.
56. Karpas A, Dremucheva A, Czepulkowski BH: A human myeloma cell line suitable for the generation of human monoclonal antibodies. Proc Natl Acad Sci USA 2001; 98: 1799-1804.
57. Traggiai E, Becker S, Subbarao K, et al: An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med 2004; 10: 871-875.
58. Meijer PJ, Andersen PS, Haahr Hansen M, et al: Isolation of human antibody repertoires with preservation of the natural heavy and light chain pairing. J Mol Biol 2006; 358: 764-772.
59. Kwakkenbos MJ, Diehl SA, Yasuda E, et al: Generation of stable monoclonal antibodyproducing B cell receptor-positive human memory B cells by genetic programming. Nat Med 2010; 16: 123-128.
60. Aalberse RC, Crameri R: IgE-binding epitopes: a reappraisal. Allergy 2011; 66: 1261-1274.
61. Horst A, Hunzelmann N, Arce S, et al: Detection and characterization of plasma cells in peripheral blood: correlation of IgE+ plasma cell frequency with IgE serum titre. Clin Exp Immunol 2002; 130: 370-378.
62. Eckl-Dorna J, Niederberger V: What is the source of serum allergen-specific IgE Curr Allergy Asthma Rep 2013; 13: 281-287.
63. Visco V, Dolecek C, Denepoux S, et al: Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1. J Immunol 1996; 157: 956-962.
64. van de Veen W, de Jong M, Stanic B, et al: Phenotypic and functional characterization of human allergen-specific memory B cells (abstract 54). EAACI-WAO Congress, Milan, 2013.
65. James LK, Bowen H, Calvert RA, et al: Allergen specificity of IgG 4 -expressing B cells in patients with grass pollen allergy undergoing immunotherapy. J Allergy Clin Immunol 2012; 130: 663-670.
66. Patil SU, Ogunniyi AO, Kubala S: Induction of antigen-specific B cells using novel tetramer- based approach occurs early during peanut oral immunotherapy (abstract 1291). EAACI-WAO Congress, Milan, 2013.
67. McCafferty J, Griffiths AD, Winter G, Chiswell DJ: Phage antibodies: filamentous phage displaying antibody variable domains. Nature 1990; 348: 552-554.
68. Smith GP: Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985; 228: 1315-1317.
69. Burton DR, Barbas CF 3rd, Persson MA, et al: A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci USA 1991; 88: 10134-10137.
70. Benichou J, Ben-Hamo R, Louzoun Y, Efroni S: Rep-Seq: uncovering the immunological repertoire through next-generation sequencing. Immunology 2012; 135: 183-191.
71. Saggy I, Wine Y, Shefet-Carasso L, et al: Antibody isolation from immunized animals: comparison of phage display and antibody discovery via V gene repertoire mining. Protein Eng Des Sel 2012; 25: 539-549.
72. Derda R, Tang SK, Li SC, et al: Diversity of phage-displayed libraries of peptides during panning and amplification. Molecules 2011; 16: 1776-1803.
73. Matochko WL, Chu K, Jin B, et al: Deep sequencing analysis of phage libraries using Illumina platform. Methods 2012; 58: 47-55.
74. Steinberger P, Kraft D, Valenta R: Construction of a combinatorial IgE library from an allergic patient. Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, Phl p 5. J Biol Chem 1996; 271: 10967-10972.
75. Hecker J, Diethers A, Schulz D, et al: An IgE epitope of Bet v 1 and fagales PR10 proteins as defined by a human monoclonal IgE. Allergy 2012; 67: 1530-1537.
76. Persson H, Karbalaei Sadegh M, Greiff L, Ohlin M: Delineating the specificity of an IgEencoding transcriptome. J Allergy Clin Immunol 2007; 120: 1186-1192.
77. Flicker S, Steinberger P, Ball T, et al: Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity. J Allergy Clin Immunol 2006; 117: 1336-1343.
78. Levin M, Rydnert F, Kallstrom E, et al: Phl p 1-specific human monoclonal IgE and design of a hypoallergenic group 1 grass pollen allergen fragment. J Immunol 2013; 191: 551-560.
79. Persson H, Flicker S, Karbalaei Sadegh M, et al: A common idiotype in IgE and its relation to recognition of the grass pollen allergen Phl p 2. Mol Immunol 2008; 45: 2715-2720.
80. Flicker S, Steinberger P, Norderhaug L, et al: Conversion of grass pollen allergen-specific human IgE into a protective IgG1 antibody. Eur J Immunol 2002; 32: 2156-2162.
81. Padavattan S, Flicker S, Schirmer T, et al: High-affinity IgE recognition of a conformational epitope of the major respiratory allergen Phl p 2 as revealed by X-ray crystallography. J Immunol 2009; 182: 2141-2151.
82. Flicker S, Vrtala S, Steinberger P, et al: A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domain. J Immunol 2000; 165: 3849-3859.
83. Andreasson U, Flicker S, Lindstedt M, et al: The human IgE-encoding transcriptome to assess antibody repertoires and repertoire evolution. J Mol Biol 2006; 362: 212-227.
84. Persson J, Augustsson P, Laurell T, Ohlin M: Acoustic microfluidic chip technology to facilitate automation of phage display selection. FEBS J 2008; 275: 5657-5666.
85. Madritsch C, Flicker S, Scheiblhofer S, et al: Recombinant monoclonal human immunoglobulin E to investigate the allergenic activity of major grass pollen allergen Phl p 5. Clin Exp Allergy 2011; 41: 270-280.
86. Hecker J, Diethers A, Etzold S, et al: Generation and epitope analysis of human monoclonal antibody isotypes with specificity for the timothy grass major allergen Phl p 5a. Mol Immunol 2011; 48: 1236-1244.
87. Christensen LH, Riise E, Bang L, Zhang C, Lund K: Isoallergen variations contribute to the overall complexity of effector cell degranulation: effect mediated through differentiated IgE affinity. J Immunol 2010; 184: 4966-4972.
88. Christensen LH, Holm J, Lund G, Riise E, Lund K: Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. J Allergy Clin Immunol 2008; 122: 298-304.
89. Niemi M, Jylha S, Laukkanen ML, et al: Molecular interactions between a recombinant IgE antibody and the -lactoglobulin allergen. Structure 2007; 15: 1413-1421.
90. Jylha S, Makinen-Kiljunen S, Haahtela T, et al: Selection of recombinant IgE antibodies binding the -lactoglobulin allergen in a conformation- dependent manner. J Immunol Methods 2009; 350: 63-70.
91. Laukkanen ML, Makinen-Kiljunen S, Isoherranen K, et al: Hevein-specific recombinant IgE antibodies from human single-chain antibody phage display libraries. J Immunol Methods 2003; 278: 271-281.
92. Yamada M, Wasserman R, Reichard BA, et al: Preferential utilization of specific immunoglobulin heavy chain diversity and joining segments in adult human peripheral blood B lymphocytes. J Exp Med 1991; 173: 395-407.
93. Wu TT, Johnson G, Kabat EA: Length distribution of CDRH3 in antibodies. Proteins 1993; 16: 1-7.
94. Souto-Carneiro MM, Sims GP, Girschik H, Lee J, Lipsky PE: Developmental changes in the human heavy chain CDR3. J Immunol 2005; 175: 7425-7436.
95. Kohler G, Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-497.
96. Bottcher I, Hammerling G: Continuous production of monoclonal mouse IgE antibodies with known allergenic specificity by a hybrid cell line. Nature 1978; 275: 761-762.
97. Liu FT, Bohn JW, Ferry EL, et al: Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol 1980; 124: 2728-2737.
98. Rudolph AK, Burrows PD, Wabl MR: Thirteen hybridomas secreting hapten-specific immunoglobulin E from mice with Ig a or Ig b heavy chain haplotype. Eur J Immunol 1981; 11: 527-529.
99. Larrick JW, Danielsson L, Brenner CA, et al: Rapid cloning of rearranged immunoglobulin genes from human hybridoma cells using mixed primers and the polymerase chain reaction. Biochem Biophys Res Commun 1989; 160: 1250-1256.
100. Li ZD, Yeh M: Construction and diversity analysis of a murine IgE phage surface display library. Cell Res 1997; 7: 161-170.
101. Gritzmacher CA, Liu FT: Expression of a recombinant murine IgE in transfected myeloma cells. J Immunol 1987; 138: 324-329.
102. Boulianne GL, Hozumi N, Shulman MJ: Production of functional chimaeric mouse/ human antibody. Nature 1984; 312: 643-646.
103. Morrison SL, Johnson MJ, Herzenberg LA, Oi VT: Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci USA 1984; 81: 6851-6855.
104. Neuberger MS, Williams GT, Mitchell EB, et al: A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature 1985; 314: 268-270.
105. Schuurman J, Perdok GJ, Lourens TE, et al: Production of a mouse/human chimeric IgE monoclonal antibody to the house dust mite allergen Der p 2 and its use for the absolute quantification of allergen-specific IgE. J Allergy Clin Immunol 1997; 99: 545-550.
106. Rodin DV, Kolesnikov VA, Srdiuk OV, et al: Synthesis of chimeric IgE in vivo after ballistic transfection of immunoglobulin genes in various mouse tissues. Mol Biol (Mosk) 2000; 34: 18-23.
107. Furtado PB, McElveen JE, Gough L, et al: The production and characterisation of a chimaeric human IgE antibody, recognising the major mite allergen Der p 1, and its chimaeric human IgG1 anti-idiotype. Mol Pathol 2002; 55: 315-324.
108. Jakobsen CG, Bodtger U, Kristensen P, Poulsen LK, Roggen EL: Isolation of highaffinity human IgE and IgG antibodies recognising Bet v 1 and Humicola lanuginosa lipase from combinatorial phage libraries. Mol Immunol 2004; 41: 941-953.
109. Geyer CR, McCafferty J, Dubel S, Bradbury AR, Sidhu SS: Recombinant antibodies and in vitro selection technologies. Methods Mol Biol 2012; 901: 11-32.
110. de Lalla C, Tamborini E, Longhi R, et al: Human recombinant antibody fragments specific for a rye-grass pollen allergen: characterization and potential applications. Mol Immunol 1996; 33: 1049-1058.
111. Braren I, Blank S, Seismann H, et al: Generation of human monoclonal allergen-specific IgE and IgG antibodies from synthetic antibody libraries. Clin Chem 2007; 53: 837-844.
112. Pomes A: Relevant B cell epitopes in allergic disease. Int Arch Allergy Immunol 2010; 152: 1-11.
113. Gieras A, Cejka P, Blatt K, et al: Mapping of conformational IgE epitopes with peptidespecific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1. J Immunol 2011; 186: 5333-5344.
114. Geysen HM, Rodda SJ, Mason TJ: A priori delineation of a peptide which mimics a discontinuous antigenic determinant. Mol Immunol 1986; 23: 709-715.
115. Meloen RH, Puijk WC, Slootstra JW: Mimotopes: realization of an unlikely concept. J Mol Recogn 2000; 13: 352-359.
116. Devlin JJ, Panganiban LC, Devlin PE: Random peptide libraries: a source of specific protein binding molecules. Science 1990; 249: 404-406.
117. Scott JK, Smith GP: Searching for peptide ligands with an epitope library. Science 1990; 249: 386-390.
118. Tribbick G: Multipin peptide libraries for antibody and receptor epitope screening and characterization. J Immunol Methods 2002; 267: 27-35.
119. Negi SS, Braun W: Automated detection of conformational epitopes using phage display peptide sequences. Bioinform Biol Insights 2009; 3: 71-81.
120. DallAntonia F, Gieras A, Devanaboyina SC, Valenta R, Keller W: Prediction of IgE-binding epitopes by means of allergen surface comparison and correlation to cross-reactivity. J Allergy Clin Immunol 2011; 128: 872-879.e8.
121. Mirza O, Henriksen A, Ipsen H, et al: Dominant epitopes and allergic cross-reactivity: complex formation between a Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1. J Immunol 2000; 165: 331-338.
122. Padavattan S, Schirmer T, Schmidt M, et al: Identification of a B-cell epitope of hyaluronidase, a major bee venom allergen, from its crystal structure in complex with a specific Fab. J Mol Biol 2007; 368: 742-752.
123. Li M, Gustchina A, Alexandratos J, et al: Crystal structure of a dimerized cockroach allergen Bla g 2 complexed with a monoclonal antibody. J Biol Chem 2008; 283: 22806-22814.
124. Valenta R, Kraft D: Recombinant allergen molecules: tools to study effector cell activation. Immunol Rev 2001; 179: 119-127.
125. Chruszcz M, Pomes A, Glesner J, et al: Molecular determinants for antibody binding on group 1 house dust mite allergens. J Biol Chem 2012; 287: 7388-7398.
126. Bostrom J, Yu SF, Kan D, et al: Variants of the antibody herceptin that interact with HER2 and VEGF. Science 2009; 323: 1610-1614.
127. Ohlin M, Owman H, Mach M, Borrebaeck CAK: Light chain shuffling of a high affinity antibody results in a drift in epitope recognition. Mol Immunol 1996; 33: 47-56.
128. Poulsen TR, Jensen A, Haurum JS, Andersen PS: Limits for antibody affinity maturation and repertoire diversification in hypervaccinated humans. J Immunol 2011; 187: 4229-4235.
129. Valenta R, Lidholm J, Niederberger V, et al: The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999; 29: 896-904.
130. Melioli G, Marcomini L, Agazzi A, et al: The IgE repertoire in children and adolescents resolved at component level: a cross-sectional study. Pediatr Allergy Immunol 2012; 23: 433-440.
131. Scala E, Alessandri C, Bernardi ML, et al: Cross-sectional survey on immunoglobulin E reactivity in 23,077 subjects using an allergenic molecule-based microarray detection system. Clin Exp Allergy 2010; 40: 911-921.
132. Scala E, Alessandri C, Palazzo P, et al: IgE recognition patterns of profilin, PR-10, and tropomyosin panallergens tested in 3,113 allergic patients by allergen microarray-based technology. Plos One 2011; 6:e24912.
133. De Knop KJ, Verweij MM, Grimmelikhuijsen M, et al: Age-related sensitization profiles for hazelnut (Corylus avellana) in a birch-endemic region. Pediatr Allergy Immunol 2011; 22:e139-e149.
134. Asher MI, Montefort S, Bjorksten B, et al: Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-743.
135. Kulig M, Bergmann R, Klettke U, et al: Natural course of sensitization to food and inhalant allergens during the first 6 years of life. J Allergy Clin Immunol 1999; 103: 1173-1179.
136. Kulig M, Klettke U, Wahn V, et al: Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol 2000; 106: 832-839.
137. Niederberger V, Niggemann B, Kraft D, Spitzauer S, Valenta R: Evolution of IgM, IgE and IgG(1-4) antibody responses in early childhood monitored with recombinant allergen components: implications for class switch mechanisms. Eur Immunol 2002; 32: 576-584.
138. Lupinek C, Marth K, Niederberger V, Valenta R: Analysis of serum IgE reactivity profiles with microarrayed allergens indicates absence of de novo IgE sensitizations in adults. J Allergy Clin Immunol 2012; 130: 1418-1420.
139. Hatzler L, Panetta V, Lau S, et al: Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol 2012; 130: 894-901.
140. Bousquet J, Anto J, Auffray C, et al: MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy 2011; 66: 596-604.
141. Marth K, Novatchkova M, Focke-Tejkl M, et al: Tracing antigen signatures in the human IgE repertoire. Mol Immunol 2010; 47: 2323-2329.
142. Collins AM, Thelian D, Basil M: Antigen valency as a determinant of the responsiveness of IgE-sensitized rat basophil leukemia cells. Int Arch Allergy Immunol 1995; 107: 547-556.
143. Lund G, Willumsen N, Holm J, et al: Antibody repertoire complexity and effector cell biology determined by assays for IgE-mediated basophil and T-cell activation. J Immunol Methods 2012; 383: 4-20.
144. Holm J, Willumsen N, Wurtzen PA, Christensen LH, Lund K: Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity. J Allergy Clin Immunol 2011; 127: 1029-1037.
145. Willumsen N, Holm J, Christensen LH, Wurtzen PA, Lund K: The complexity of allergic patients IgE repertoire correlates with serum concentration of allergen-specific IgE. Clin Exp Allergy 2012; 42: 1227-1236.
146. Gieras A, Focke-Tejkl M, Ball T, et al: Molecular determinants of allergen-induced effector cell degranulation. J Allergy Clin Immunol 2007; 119: 384-390.
147. van der Heijden FL, van Neerven RJ, van Katwijk M, Bos JD, Kapsenberg ML: Serum- IgE-facilitated allergen presentation in atopic disease. J Immunol 1993; 150: 3643-3650.
148. Jiang N, He J, Weinstein JA, et al: Lineage structure of the human antibody repertoire in response to influenza vaccination. Sci Transl Med 2013; 5: 171ra19 .
149. Mersmann M, Meier D, Mersmann J, et al: Towards proteome scale antibody selections using phage display. N Biotechnol 2010; 27: 118-128.
150. Turunen L, Takkinen K, Soderlund H, Pulli T: Automated panning and screening procedure on microplates for antibody generation from phage display libraries. J Biomol Screen 2009; 14: 282-293.
151. Levin M, Davies AM, Liljekvist M, et al: Human IgE against the major allergen Bet v1 - defining an epitope with limited cross-reactivity between different PR-10 family proteins. Clin Exp Allergy 2013, DOI: 10.1111/ cea.12230.